Pulmonális artériás hipertónia: vizsgálatok itt: Kanada

In Kanada 15 Also abroad 311

15 trials · From ClinicalTrials.gov, checked 2026. november 14.. Ask the study team whether a trial fits you.

4. fázisTaking people
Sotatercept in Pulmonary Arterial Hypertension
Where
Edmonton
Életkor
18 év and over
People
27
Run by
University of Alberta
See details and how to joinNCT07140484
2. fázisTaking people
Feasibility Trial for a Right Ventricular Failure Platform Trial
Where
Calgary, Edmonton, London, Ottawa, Vancouver
Életkor
18 év and over
People
30
Run by
University of Alberta
See details and how to joinNCT06570473
3. fázisTaking people
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
Where
Calgary
Életkor
18 év to 80 év
People
344 worldwide
Run by
Liquidia Technologies, Inc.
See details and how to joinNCT07285655
3. fázisTaking people
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
Where
Calgary, London, Ottawa, Toronto
Életkor
18 év to 75 év
People
330 worldwide
Run by
Gossamer Bio USA, Inc.
See details and how to joinNCT06274801 · EU 2023-506334-75-00
2. fázisTaking people
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
Where
Calgary, London
Életkor
18 év to 80 év
People
40 worldwide
Run by
AllRock Bio, Inc.
See details and how to joinNCT07175038 · EU 2025-522074-37-00
3. fázisCsak meghívásos
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
Where
Calgary, Edmonton, London, Montreal, Québec, Toronto
Életkor
18 év and over
People
1000 worldwide
Run by
United Therapeutics
See details and how to joinNCT03683186 · EU 2023-509305-68-00
No phaseTaking people
PET/MR Pre- and Post Radiotherapy for Cardiopulmonary Dysfunction Evaluation
Where
Toronto
Életkor
18 év and over
People
40
Run by
University Health Network, Toronto
See details and how to joinNCT04901884
No phaseNot yet taking people in Kanada
Withdrawal of Prostacyclin Pathway Therapy in Patients With Pulmonary Arterial Hypertension Receiving Sotatercept (WATERLOO)
Where
Edmonton
Életkor
18 év and over
People
78
Run by
University of Alberta
See details and how to joinNCT07700303
1/2. fázisTaking people
DIAG723 in Adults With Hereditary Hemorrhagic Telangiectasia
Where
Laval, Toronto
Életkor
18 év and over
People
93 worldwide
Run by
Diagonal Therapeutics, Inc.
See details and how to joinNCT07623525
3. fázisTaking people
An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
Where
Edmonton
Életkor
18 év to 75 év
People
486 worldwide
Run by
Inhibikase Therapeutics
See details and how to joinNCT07365332 · EU 2024-520218-23-00
No phaseTaking people
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Where
Montreal, Toronto
Életkor
0 év to 20 év
People
5000 worldwide
Run by
Duke University
See details and how to joinNCT04278404
No phaseTaking people
MedlyPeds Feasibility Study
Where
Toronto
Életkor
8 év to 18 év
People
30
Run by
The Hospital for Sick Children
See details and how to joinNCT07556185
No phaseTaking people
Safety and PK-PD Study of Oral L-CIT in Preterm Infants With BPD±PH and NEC
Where
Toronto
Életkor
1 hónap to 6 hónap
People
36
Run by
The Hospital for Sick Children
See details and how to joinNCT05636397
No phaseTaking people
Functional Pulmonary Capillary Surface Area in BPA for CTEPH
Where
Montreal
Életkor
18 év to 75 év
People
40
Run by
Jewish General Hospital
See details and how to joinNCT05719415
No phaseTaking people
Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry
Where
Edmonton
Életkor
1 nap to 21 év
People
2500 worldwide
Run by
New York Medical College
See details and how to joinNCT02249923